Manulife (Manufacturers Life Insurance)’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-736
| Closed | -$23.4K | – | 3013 |
|
2023
Q3 | $23.4K | Buy |
+736
| New | +$23.4K | ﹤0.01% | 2956 |
|
2022
Q2 | – | Sell |
-1,441
| Closed | -$53.2K | – | 3119 |
|
2022
Q1 | $53.2K | Sell |
1,441
-273
| -16% | -$10.1K | ﹤0.01% | 3036 |
|
2021
Q4 | $168 | Buy |
1,714
+44
| +3% | +$4 | ﹤0.01% | 2955 |
|
2021
Q3 | $208K | Sell |
1,670
-112
| -6% | -$14K | ﹤0.01% | 2958 |
|
2021
Q2 | $223K | Buy |
1,782
+371
| +26% | +$46.4K | ﹤0.01% | 3025 |
|
2021
Q1 | $192K | Sell |
1,411
-99
| -7% | -$13.5K | ﹤0.01% | 2907 |
|
2020
Q4 | $137K | Buy |
1,510
+67
| +5% | +$6.08K | ﹤0.01% | 2895 |
|
2020
Q3 | $107K | Hold |
1,443
| – | – | ﹤0.01% | 2781 |
|
2020
Q2 | $122K | Buy |
+1,443
| New | +$122K | ﹤0.01% | 2686 |
|
2019
Q2 | – | Sell |
-389
| Closed | -$28K | – | 2953 |
|
2019
Q1 | $28K | Buy |
+389
| New | +$28K | ﹤0.01% | 2613 |
|
2018
Q3 | – | Sell |
-534
| Closed | -$213K | – | 3701 |
|
2018
Q2 | $213K | Buy |
534
+471
| +748% | +$188K | ﹤0.01% | 3083 |
|
2018
Q1 | $19K | Sell |
63
-47
| -43% | -$14.2K | ﹤0.01% | 3765 |
|
2017
Q4 | $33K | Sell |
110
-292
| -73% | -$87.6K | ﹤0.01% | 3652 |
|
2017
Q3 | $219K | Buy |
402
+27
| +7% | +$14.7K | ﹤0.01% | 2910 |
|
2017
Q2 | $224K | Buy |
375
+335
| +838% | +$200K | ﹤0.01% | 2915 |
|
2017
Q1 | $17K | Buy |
40
+38
| +1,900% | +$16.2K | ﹤0.01% | 3568 |
|
2016
Q4 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 4216 |
|